Banner Top
Sunday, November 27, 2022
Point of Care Diagnostics Market to Reach $55.3 Billion at 6.5% CAGR During the Forecast Period 2021 to 2030

Point of care diagnostics market report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics.

 

Point of care diagnostics market size was valued at $29,478.63 million in 2020, and is estimated to reach $55.3 Billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030. Point-of-care (POC) diagnostic devices defined in this report are medical devices, which imply in the POC diagnostic procedures, used primarily in the investigation of various diseases, such as cancer, diabetes, cardiac diseases, and others. They allow healthcare professionals to diagnose and treat these medical conditions by analyzing the causes of diseases. The adoption of these devices increases among the professionals because they provide immediate direction for accurate treatment by offering instant diagnosis results. In addition, technological advancements in the POC diagnostic devices, such as the launch of innovative and advanced glucose monitoring kits and pregnancy and fertility kits have attracted end-users to adopt the devices for the testing and diagnosis procedures.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

• Johnson and Johnson
• Sysmex Corporation
• Nova Biomedical
• Danaher Corporation
• Becton Dickinson and Company
• bioMrieux SA
• Abbott Laboratories
• Siemens AG
• Hoffmann La Roche Ltd
• Sinocare Inc.

 

By product, the point-of-care diagnostic kit market is segmented into glucose monitoring kit, infectious diseases testing kit, pregnancy, and fertility testing kit, hematology testing kit, cardiometabolic monitoring kit, urinalysis testing kit, coagulation monitoring kit, tumor markers testing kit, cholesterol test strips, drug of abusee testing kit, fecal occult testing kit, and others. Glucose monitoring segments dominate the market owing to the rise in the diabetic patient population, especially in developing countries, and the growing demand for glucose testing.

On the basis of end-user, the global point-of-care diagnostic market is segmented into professional diagnostic centers, research laboratories, homes, and others, such as medical universities, not-for-profit organizations, and nursing homes. Among these end users, the professional diagnostic centers dominate in the global point-of-care diagnostic market due to the rise in frequency of chronic diseases requiring long-term care and regular monitoring in critical care units, as well as the fast-developing knowledge of the availability of cost-effective and highly creative POC diagnostic instruments.

By region, the Point of Care Diagnostics Industry is classified into North America, Europe, Asia Pacific, and LAMEA. North America garnered a major share of the point-of-care diagnostic market in 2020 and is expected to continue to dominate during the forecast period, owing to rise in cases of chronic diseases, such as diabetes and cancer, and a growing old age population is all expected to boost demand for point-of-care diagnostics in the region. However, Asia-Pacific is expected to register highest from 2021 to 2030.

Banner Content